coagulation parameters

Related by string. * Coagulation : disseminated intravascular coagulation . coagulation factor VIIa . Colorado Coagulation Endocrine Sciences . coagulation factors . coagulation disorders . blood coagulation disorders / Parameters . PARAMETERS : physiological parameters . metabolic parameters . qualitative parameters . pharmacodynamic parameters . lipid parameters * *

Related by context. All words. (Click for frequent words.) 68 transfusion syndrome 67 CYP#A# substrates 67 radiographic findings 66 hsCRP levels 66 symptomatic intracranial 66 Subgroup analysis 66 postoperative complication 65 symptomatic VTE 65 glomerular filtration 65 serum aminotransferase levels 65 aminotransferases 65 Thrombin JMI designed 65 intravascular hemolysis 65 troponins 65 intima media thickness 65 pulmonary toxicity 65 intraoperative complications 65 radiosensitivity 65 paricalcitol 65 cervical lymph nodes 64 thrombotic complications 64 metabolite concentrations 64 cerebral angiography 64 hepatic arterial 64 perfusion MRI 64 FGFR2 gene 64 Tasigna prolongs 64 transthyretin 64 cerebral spinal 64 periocular 64 leiomyoma 64 histological examination 64 cortical atrophy 64 gastroduodenal 64 pseudoaneurysm 64 intraoperatively 64 microsatellite instability 64 systolic function 64 colorectal neoplasms 64 hematologic parameters 64 variant angina 64 QTc prolongation 63 colorectal adenoma 63 QTcF 63 PLX STROKE targeting 63 intra abdominal abscess 63 C telopeptide 63 p# activation 63 lactate dehydrogenase 63 N telopeptide 63 CD# expression [001] 63 hepatic enzymes 63 Helicobacter infection 63 β blockers 63 pituitary hormone 63 transmural 63 thyroid hormone levels 63 creatinine levels 63 hypoperfusion 63 intracranial bleeding 63 ventricular tachyarrhythmia 63 retinal ischemia 63 intact parathyroid hormone 63 anticoagulant medication 63 EXJADE 63 sonographically guided 63 torsade de pointes 63 DNA methylation patterns 63 CLA supplementation 63 transthoracic 63 PASI scores 63 Randomized clinical trials 63 morphometric vertebral fractures 63 RVOT 63 gadolinium enhanced 63 lactate dehydrogenase LDH 63 mutated KRAS 63 thrombo embolic 63 abnormal genital 63 impair fertility 63 Hypotension 63 hypervascular tumors 63 inflamed tissues 62 glomerular 62 flecainide 62 TOP2A gene 62 percutaneous biopsy 62 vitamin B# folic acid 62 parenchymal 62 prolonged QT interval 62 immunostaining 62 scintigraphic 62 mucosal lesions 62 diabetic kidney 62 colorectal adenocarcinoma 62 serum calcium levels 62 colon perforation 62 Ribavirin causes 62 haematologic 62 Postoperatively 62 MTHFD1L gene 62 ischemia induced 62 argatroban 62 fibrin clot 62 anaphylactic reactions bronchospasm 62 myocyte 62 BEXXAR Therapeutic Regimen 62 hamartoma 62 rtPA 62 eosinophil count 62 intestinal motility 62 normal karyotype 62 oral anticoagulant therapy 62 autoregulation 62 antiplatelet medications 62 genotypic resistance 62 hypervascular 62 QTc intervals 62 PRADAXA #mg 62 osteolytic 62 Retrograde ejaculation 62 umbilical vein 62 carotid artery blockage 62 cardiac repolarization 62 fatty infiltration 62 nonvertebral fracture 62 bronchoalveolar lavage 62 PSADT 62 systemic hypotension 62 QT intervals 62 perioperatively 62 analgesic medications 62 nodular lesions 62 tryptase 62 intraventricular 62 angiographically 62 serum phosphorous 62 postoperative hemorrhage 62 T1 weighted images 62 endometrial thickness 62 desmin 62 bronchial reactivity 62 survivin expression 62 CYP#A# substrate 62 sonographic appearance 62 malperfusion 62 Cardiopulmonary bypass 62 Histopathologic examination 62 AGTR1 62 liver histology 61 ADAMTS# 61 gonadotrophin releasing hormone 61 echocardiographic parameters 61 bovine thrombin 61 bullous 61 brain lesions 61 microcirculatory 61 hepatic vein 61 BRAF gene mutations 61 GnRH agonist 61 transesophageal echocardiography 61 intracerebral 61 conditional logistic regression 61 aPTT 61 intravenous cyclophosphamide 61 electrophysiologic 61 K ras mutations 61 myocardial reperfusion 61 61 hematological parameters 61 beta blocker therapy 61 platelet dysfunction 61 fibrin deposition 61 thyroglobulin 61 retrograde ejaculation 61 spirometric 61 contractile function 61 lumbar disk herniation 61 intima media thickness IMT 61 postprocedure 61 Fanconi syndrome 61 antigenicity 61 hydrops 61 histologic findings 61 artery stenosis 61 JAK mutations 61 cisplatin resistant 61 PCNSL 61 arterial inflammation 61 vascular reactivity 61 tumor necrosis 61 FDG uptake 61 Multivariate logistic regression 61 IV bisphosphonates 61 mucinous 61 TMPRSS2 ERG fusion 61 Heavy menstrual bleeding 61 deep venous thromboses 61 Optic nerve 61 ventricular septum 61 dose proportionality 61 nerve degeneration 61 skeletal myoblasts 61 pamidronate 61 transabdominal 61 molar pregnancy 61 biopsy specimen 61 lesional 61 splenic 61 abdominal computed tomography 61 skeletal muscle tissue 61 coagulation assays 61 lichen planus 61 thyrotropin 61 nonischemic 61 vascularisation 61 neurologic outcomes 61 anterior pituitary 61 foveal thickness 61 computed tomographic scan 61 fetal malformations 61 biochemical relapse 61 wound dehiscence 61 allogeneic HSCT 61 d dimer 61 arterial venous 61 receiving XGEVA 61 serum phosphate 61 clomipramine 61 plasma creatinine 61 tumor subtype 61 hemodilution 61 left ventricular diastolic 61 OGG1 61 severe hypersensitivity reactions 61 gastrointestinal perforations 61 sonographically 61 jejunal 61 serum cortisol 61 stent graft placement 61 cardiac tamponade 61 hyperacute 61 perfusion defects 61 aromatase inhibitor therapy 61 craniectomy 61 mucocutaneous reactions 61 carotid IMT 61 ovarian hormones 61 leukocyte counts 61 renal fibrosis 61 agonist induced 61 ß amyloid 61 vascular dysfunction 60 myocardial ischemia 60 atrioventricular valve 60 fusion enhancers 60 radioiodine therapy 60 left ventricular systolic 60 atheroma volume 60 PR interval prolongation 60 HER2 positivity 60 oxidized lipids 60 pulmonary artery banding 60 relapsed MM 60 arteriolar 60 hypovolemic 60 neoplastic cells 60 MS relapses 60 troponin T 60 Thal Dex 60 activated partial thromboplastin 60 coagulopathy 60 axillary node 60 microvessels 60 AST ALT 60 histological subtype 60 bronchoalveolar 60 Febrile neutropenia 60 Erythropoietic therapies may 60 recurrent venous thromboembolism 60 parathyroid carcinoma 60 NFKBIA 60 immunohistochemical analysis 60 HER2 expression 60 genes CYP#C# 60 cerebro spinal fluid 60 synovial cells 60 body habitus 60 reinfarction 60 Oral corticosteroids 60 rebleeding 60 aspartate aminotransferase AST 60 cardiopulmonary bypass surgery 60 glycosylated hemoglobin HbA1c 60 neutrophil counts 60 motor neuron degeneration 60 pressure tachycardia diaphoresis 60 thyrotoxicosis 60 hyperalgesia 60 serum lipid 60 nimodipine 60 Western blotting 60 warfarin dosage 60 sustained ventricular tachycardia 60 upper GI tract 60 telomerase inhibition 60 platelet activation 60 hepatic toxicity 60 Ileus 60 IgA deficiency 60 antibiotics ciprofloxacin 60 experimentally induced 60 colon resection 60 Postoperative complications 60 coagulation disorders 60 natriuresis 60 ventricular tachyarrhythmias 60 thyrotropin levels 60 PTHrP 60 microglial activation 60 pleural fluid 60 INVEGA ™ 60 adenomyosis 60 Clinically significant 60 QT interval prolongation 60 statins cholesterol lowering 60 ventricular remodeling 60 carcinoids 60 glycosylated hemoglobin levels 60 nasopharyngitis headache 60 vasogenic edema 60 fumagillin nanoparticles 60 renal allograft 60 Insulin sensitivity 60 Histologic 60 Hurthle cell 60 streptokinase 60 Duodenal 60 ventricular dilation 60 metabolic abnormality 60 hemoglobin hematocrit 60 chromosomal aberrations 60 nodal metastasis 60 Immunohistochemical staining 60 beta adrenergic receptor 60 stratifying patients 60 Known hypersensitivity 60 recurrent ischemia 60 myofibroblasts 60 BDNF gene 60 lymphomas leukemias 60 trophoblast cells 60 histologically 60 epididymal 60 barium swallow 60 lung metastasis 60 DNA hypermethylation 60 hamartomas 60 thrombus formation 60 neurocognitive function 60 haemolysis 60 endometrial biopsy 60 dactylitis 60 bezafibrate 60 explants 60 intrathoracic 60 neurologic symptoms 60 vasospasm 60 chest radiographs 60 cAMP signaling 60 pretransplant 60 parasitemia 60 dysplastic lesions 60 HER2 overexpression 60 CYT# potent vascular disrupting 60 arterial stenosis 60 plasma kallikrein inhibitor 60 distensibility 60 vasodilatation 60 mucous membrane lining 60 pelvic ultrasound 60 intimal hyperplasia 60 SOD2 gene 60 Acute pancreatitis 60 anterior temporal 60 leukocytosis 60 cortisol concentrations 60 thrombocytopenic 60 choroidal neovascularization 60 acute aortic dissection 60 malignant polyps 60 histopathologic examination 60 vascular occlusion 60 ADPKD 60 Intravenous immunoglobulin 60 amyloid deposition 60 pulmonary artery catheterization 60 serum calcium 60 p# Shc 60 cerebrovascular events 60 thyroid carcinoma 60 lung epithelium 60 hMG 60 ERK1 2 60 hepatorenal syndrome 60 mitral stenosis 60 variceal 60 anti androgen 60 pre malignant lesions 60 parkinsonian symptoms 60 tinzaparin 60 urolithiasis 60 neutropenic sepsis 60 bleeding diathesis 60 coronary revascularization procedures 60 coagulation abnormalities 60 biomechanical integrity 60 fibrinolysis 60 immunological reaction 60 nephropathy kidney 60 thyroid deficiency 60 SOCS3 60 intracoronary 60 antitumor efficacy 60 neurologic deficits 60 Fas ligand 60 cystoscopic 60 postoperative mortality 60 oncomodulin 60 gastric carcinoma 60 p# MAPK 60 Xenopus embryos 60 microvessel 60 lung edema 60 erythema nodosum 60 serum phosphate levels 60 factor PlGF 60 morphologic 60 callus formation 60 methacholine challenge 60 premalignant lesions 60 neurologic progression 60 papillary renal cell carcinoma 60 osteoblastic 60 hepatic liver 60 ximelagatran 60 antidiabetic medication 60 akinesia 60 hemodynamically stable 60 dysrhythmias 60 Teriflunomide 60 choroidal neovascularization CNV 60 pretreatment serum 60 prostate cancer metastases 59 apneic episodes 59 autonomic dysfunction 59 GI bleeds 59 Difficulty swallowing 59 serum PTH 59 ALK gene 59 perioperative morbidity 59 renal biopsy 59 Surgical excision 59 antiphospholipid antibodies 59 CYP#D# genotype 59 Genetic variants 59 electrical cardioversion 59 TNF blocker therapy 59 clefting 59 Aggrastat ® tirofiban hydrochloride 59 RQ PCR 59 cerebral vasospasm 59 glial tumors 59 endometrial hyperplasia 59 aneurysmal 59 F FDG PET 59 thromboembolic disease 59 synovial 59 tortuosity 59 gross hematuria 59 hematopoietic cancers 59 enlarged spleens 59 amyloid plaque formation 59 anaphylaxis dyspnea flushing 59 heterotopic bone 59 postoperative chemotherapy 59 liver transaminases 59 mineral density BMD 59 atheroma 59 inhibit platelet function 59 rFVIIa 59 invasive lobular 59 cortical dysplasia 59 platelet function 59 luteal 59 androgen ablation 59 Computerized tomography 59 Doppler echocardiography 59 drug eluting stent implantation 59 anemia thrombocytopenia 59 dyskeratosis congenita 59 renal cysts 59 tumor perfusion 59 noninvasive outpatient 59 noncardiac 59 infarcts 59 salpingo oophorectomy 59 Viral load 59 acoustic startle 59 prostate carcinoma 59 PrPSc 59 Carotid artery 59 metastatic malignant 59 inotropic agents 59 gastric adenocarcinoma 59 vascular anatomy 59 metabolic derangements 59 Skin lesions 59 basal bolus regimen 59 atrophic 59 peritoneal fluid 59 exploratory laparotomy 59 sensory nerve fibers 59 PTEN protein 59 metastatic lymph nodes 59 intracranial hemorrhage ICH 59 oral antidiabetes 59 hepatectomy 59 chlamydial 59 multivariate Cox 59 anticlotting drugs 59 exendin 4 59 prostate cancer CaP 59 conventional DMARDs 59 corneal astigmatism 59 elevated transaminases 59 extracapsular extension 59 adnexal mass 59 osteoporotic vertebral compression fractures 59 pentoxifylline 59 podocytes 59 eculizumab therapy 59 idraparinux 59 gastrointestinal perforation 59 antiangiogenic therapy 59 echogenicity 59 C. pneumoniae 59 esophageal reflux 59 myometrium 59 KRAS mutant tumors 59 EDARBI 59 weekly subcutaneous injections 59 thrombocytopenic patients 59 ABCB1 59 anticonvulsant medication 59 postoperative morbidity 59 urethral stricture 59 osteoid 59 locoregional recurrence 59 postoperative bleeding 59 carotid artery thickness 59 therapeutic regimens 59 INVEGA ® 59 gastric mucosa 59 alanine aminotransferase 59 renal flares 59 myocardial infarction ventricular fibrillation 59 intravenous bisphosphonates 59 T2 lesions 59 repolarization 59 leiomyomas 59 LV dysfunction 59 mediastinal lymph nodes 59 seroma formation 59 CMV infections 59 Revascor ™ 59 polyomavirus nephropathy 59 neuritic 59 C1q 59 FUS protein 59 Akt activation 59 mutated K ras 59 underwent balloon angioplasty 59 metabolic parameters 59 hepatic function 59 oral hypoglycemic agents 59 neurodevelopmental outcome 59 micrometastasis 59 TGF beta pathway 59 FDG-PET/CT 59 Postoperative 59 hepatic lesions 59 CYP #D# 59 detectable HCV RNA 59 serum creatinine levels 59 dobutamine 59 pacemaker ICD 59 BYSTOLIC 59 NATRECOR ® 59 Xelox 59 meta regression 59 Fetal heartbeats 59 fibrate drugs 59 vertebrobasilar 59 FUSILEV enhances 59 hypermethylated 59 epithelial tumors 59 Non inferiority 59 fluvastatin 59 malignant prostate 59 transrectal ultrasound guided 59 Computed tomography 59 endothelial activation 59 leucopenia 59 leflunomide 59 fetal chromosomal 59 ERK activation 59 submucosal 59 thrombophlebitis 59 wedge resection 59 LVNC 59 steroid dexamethasone 59 microcirculatory improvement helping 59 methylation patterns 59 Serum creatinine 59 cerebri 59 resynchronization therapy 59 euvolemic hyponatremia 59 aneurysmal subarachnoid hemorrhage 59 EGFR protein 59 arthrography 59 intracerebral haemorrhage 59 mL/min/#.# m 2 59 microRNA expression 59 LNG IUS 59 Tranexamic acid 59 androgen hormones 59 recurrent glioblastoma multiforme 59 pancreaticoduodenectomy 59 vaso occlusive crisis 59 Chronic pancreatitis 59 trastuzumab Herceptin ® 59 tumor histology 59 apolipoprotein E4 59 Inhaled nitric oxide 59 precancerous condition 59 infarct size 59 progesterone receptor negative 59 candidemia 59 dopamine neuron 59 da mage 59 hypokalemia hypomagnesemia 59 microbleeds 59 Tumor Response 59 pyridostigmine 59 pathologic fractures 59 gooey amyloid 59 imatinib therapy 59 neurohormonal activation 59 thoracoscopic lobectomy 59 BRAF V#E mutation 59 hypoglycemic coma 59 intestinal mucosal 59 SIADH 59 percutaneous drainage 59 Darapladib 59 anemia neutropenia 59 apolipoprotein A1 59 galiximab 59 endothelium dependent 59 JAK2 enzyme 59 esophageal perforation 59 containing abacavir 59 retransplantation 59 bile acid metabolism 59 thienopyridines 59 Cholinesterase inhibitors 59 myeloperoxidase 59 coronary occlusion 59 Thalomid ® 59 Microarray analysis 59 postoperative delirium 59 chromosomal mutations 59 dyslipidemia abnormal 59 aminotransferase levels 59 cerebral arteries 59 NNT = 59 adenomatous 59 multivariable analysis 59 thyroid hormone replacement 59 anastomotic devices 59 gene rearrangements 59 endometrial carcinoma 59 peroxidation 59 pre operatively 59 temporal arteritis 59 VCUG 59 acute myocarditis 59 adiponectin levels 59 plasma pharmacokinetics 59 interstitial fibrosis 59 platelet reactivity 59 haemodynamic 59 PI3K signaling 59 Multivariate analysis 59 hemodynamically unstable 59 creatine kinase 59 histone acetylation 59 TNF antagonist 59 ZOLINZA 59 colorectal tumor 59 testicular tumors 59 COPEGUS therapy 59 appendiceal 59 vitamin D calcium 59 Post operatively 59 glycated hemoglobin levels 59 vasopressor 59 cerebral ischemia 59 albumin excretion 59 logistic regression analysis 59 cediranib 59 intra tumoral 59 liver metastasis 59 arteritis 59 LRAT 59 pancreatic endocrine 59 cTnI 59 neovascular 59 Cystatin C 59 hypertrophic scarring 59 vecuronium 58 syngeneic 58 blood clotting protein 58 serum urate levels 58 immunohistochemical staining 58 prehospital setting 58 baroreceptors 58 Hazard Ratio HR 58 VIIBRYD 58 severe dermatologic toxicities 58 infarcted 58 neointimal 58 Marfan mice 58 vessel dilation 58 Circulating tumor cells 58 Orthostatic hypotension 58 viral titers 58 bleomycin 58 fractional shortening 58 monophasic 58 mesangial 58 mycophenolic acid 58 non resectable metastatic 58 transaminase levels 58 microvessel density 58 hypertensive retinopathy 58 postoperative pulmonary 58 necrotic core 58 pulmonary angiography 58 timepoints 58 hematologic toxicity 58 fasting insulin 58 myoma 58 underwent angiography 58 esophageal motility 58 revealed multivessel coronary 58 gut motility 58 saline infusion 58 flow mediated dilation 58 blood glucose concentrations 58 infantile hemangioma 58 atherosclerosis plaque buildup 58 transcranial Doppler 58 preoperative chemotherapy 58 meningeal 58 haematomas 58 cancerous colon polyps 58 ovarian malignancy 58 HAART regimen 58 acetabular fractures 58 triiodothyronine 58 intratumoral 58 clot busting therapy 58 cardiac fibrosis 58 gadobutrol 58 vascular insufficiency 58 plain radiographs 58 malignant growths 58 Commonly prescribed 58 cytopenias 58 CIN3 58 Univariate analysis 58 syncope fainting 58 STAT3 signaling 58 biochemical abnormalities 58 myo inositol 58 subcutaneous tissues 58 monoamine neurotransmitters 58 ACh 58 procalcitonin 58 pleomorphic 58 obstructive coronary 58 hemorrhagic complications 58 aspirin clopidogrel 58 radiographic outcomes 58 mycotic 58 MMP2 58 metabolizing enzyme 58 polymorphonuclear leukocytes 58 osteoblast 58 myocardial infarct size 58 ascites fluid 58 Infusion Reactions Severe 58 ICD shocks 58 hemolytic 58 MMP inhibitor 58 arteriography 58 sitaxsentan 58 lethal arrhythmias 58 ADPKD patients 58 transvaginal sonography 58 epigenetic silencing 58 haematopoietic 58 beta globin gene 58 pulmonary dysfunction 58 prostatic fluid 58 radiographically 58 bronchoalveolar lavage BAL 58 mild renal insufficiency 58 intrahepatic 58 plasminogen activators 58 decompensated cirrhosis 58 univariate analyzes 58 TOP2A 58 Visual acuity 58 obstructive coronary artery 58 bacteriuria 58 vascularization 58 MC4R gene 58 silent ischemia 58 HNSCC 58 coronary CTA 58 intravenous diuretics 58 intracranial hemorrhage bleeding 58 neurite outgrowth 58 biochemical recurrence 58 tumor excision 58 immunoreactivity 58 abdominal ultrasounds 58 anthracycline chemotherapy 58 serum estradiol 58 antioxidant supplementation 58 lymphocytosis 58 ileal 58 pulmonary alveolar 58 IFN beta 58 skeletal metastases 58 MMSE score 58 unruptured aneurysm 58 obstructive CAD 58 esophageal lining 58 Doppler sonography 58 neurologic complications 58 Immune reconstitution syndrome 58 exocrine glands 58 inducible nitric oxide synthase 58 venous reflux 58 reduce serum phosphate 58 dopaminergic therapy 58 Hair follicle 58 extraocular 58 angiographic outcomes 58 Umbilical cord stem cells 58 systolic dysfunction 58 abdominal aneurysms 58 aminophylline 58 squamous carcinoma 58 Avandia Actos 58 collagen degradation 58 tachyarrhythmias 58 airway hyperresponsiveness 58 mutated p# 58 Immunohistochemical analysis 58 lung nodule 58 SSc 58 thrombotic thrombocytopenic purpura TTP 58 cardiopulmonary bypass CPB 58 paracentesis 58 atrioventricular block 58 thoracic aortic aneurysm 58 MGd 58 uterus womb 58 abdominal aortic 58 baseline LDH 58 HMGCR 58 pulmonary arterial 58 Losartan 58 arterial revascularization 58 histologic examination 58 Calcium intake 58 nausea emesis 58 elevated serum creatinine 58 polycystic kidneys 58 neuropathological 58 podocyte 58 persistent pulmonary hypertension 58 glutamate glutamine 58 subconjunctival 58 warfarin anticoagulation 58 elevated triglyceride levels 58 hyperoxia 58 neutropenia dehydration dyspnea 58 liver transplant recipients 58 paroxysmal supraventricular tachycardia 58 gastric varices 58 jugular venous 58 recurrent DVT 58 thyroid stimulating hormone 58 plasma lipids 58 ACTOplus met XR 58 coronary stenosis 58 Preoperatively 58 papillary carcinoma 58 shortens systolic ejection 58 histopathological 58 node metastases 58 proteoglycan 58 autophagic 58 epithelial barrier 58 HCV replication 58 pituitary adenomas 58 clinically insignificant 58 intensive lipid lowering 58 viable myocardium 58 micronuclei 58 tricuspid regurgitation 58 phenothiazines 58 trophoblastic 58 postoperative infection 58 Amino acid 58 mdx mice 58 tracer uptake 58 monoclonal gammopathy 58 TIMP 1 58 trophoblasts 58 isoprostane 58 neurosensory 58 convulsive disorders 58 hypothalamic pituitary adrenal axis 58 tamoxifen Nolvadex ® 58 bowel perforations 58 ursodeoxycholic acid 58 inotropic 58 hepatocellular carcinomas 58 rhythm disturbances 58 fibrinolytic 58 cellularity 58 prespecified secondary 58 superior mesenteric artery 58 lobar pneumonia 58 hepatic fibrosis 58 CYP#D# inhibitor 58 neurohormones 58 taxane chemotherapy administered 58 HepG2 cells 58 rHuEPO 58 hemodynamically significant 58 full thickness plication 58 mTOR inhibitors 58 ventricular arrhythmia 58 orchitis 58 antifibrinolytic 58 Radical prostatectomy 58 intracranial atherosclerosis 58 atherosclerotic lesions 58 coronary revascularization 58 surgical revascularization 58 atrophic vaginitis 58 immunosuppressive regimen 58 MDCT angiography 58 oxcarbazepine 58 embolic stroke 58 Vidaza azacitidine 58 serum BDNF 58 precancerous tissue 58 myocytes 58 intestinal polyps 58 benign nodules 58 malignant ascites 58 Teriparatide 58 nonalcoholic steatohepatitis 58 cerebral ischemic 58 ACE inhibitors dilate 58 precancerous cervical 58 imexon 58 ventricular dilatation 58 antiandrogen 58 Cell Lymphoma CTCL

Back to home page